Jonathan Gold
Clifton, NJNPI 1841219797
Payments from drug & device makers
$1,721in general payments, 2019–2025
Across 84 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$545
- Lilly USA, LLC$320
- Novartis$203
- AbbVie$155
- Pfizer$132
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$59
- plus $307 from 13 others
What the payments were for
- Food & beverage$1,40281%
- Education$31919%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $545 |
| Lilly USA, LLC | 17 | $320 |
| Novartis | 11 | $203 |
| AbbVie | 10 | $155 |
| Pfizer | 6 | $132 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $59 |
| Galderma Laboratories, L.p. | 4 | $57 |
| Mayne Pharma Commercial LLC | 3 | $46 |
| Sandoz | 2 | $32 |
| Journey Medical Corporation | 2 | $30 |
| EPI Health, LLC | 2 | $26 |
| Prugen, Inc. Pharmaceuticals | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Incyte Corporation | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.